Belite Bio Announces Appointment Of Hendrik P. N. Scholl, MD, MA, As Chief Medical Officer
SAN DIEGO, Belite Bio, Inc (NASDAQ: BLTE) (‘Belite Bio’ or the ‘Company’), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting